Jubilant Pharmova Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is FEBUXOSTAT, with a corresponding US DMF Number 30353.
Remarkably, this DMF maintains an Active status since its submission on March 30, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 22, 2017, and payment made on July 22, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II